Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Beck

Showing results (621-630 of 718) with videos related to

Pageof 72
Sort By:
JAMA Dermatology|June 12, 2024
Skin Manifestations of VEXAS Syndrome and Associated GenotypesIsabella J Tan, Marcela A Ferrada, Serene Ahmad, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 16, 2015
Rapid Response to Cyclosporin A and Favorable Renal Outcome in Nongenetic Versus Genetic Steroid-Resistant Nephrotic SyndromeAnja K Büscher, Bodo B Beck, Anette Melk, et al.
Plos One|November 16, 2018
Long-term effects of smallpox vaccination on expression of the HIV-1 co-receptor CCR5 in womenK B Beck, B L Hønge, J S Olesen, et al.
Kidney International Reports|May 20, 2021
Expanding the Spectrum of FAT1 Nephropathies by Novel Mutations That Affect Hippo SignalingFrancesca Fabretti, Nikolai Tschernoster, Florian Erger, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 21, 2025
Clinical Manifestations of VEXAS Syndrome Across a Broad Spectrum of UBA1 Mutation BurdenMeghan Anderson, Defne Ercelen, Ashley Richardson, et al.
Journal of Clinical Medicine|February 27, 2026
PAXIS: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2 Study (Part 1) Followed by an Open-Label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients with VEXAS SyndromeDavid B Beck, Maël Heiblig, Sinisa Savic, et al.
Rheumatology (Oxford, England)|March 29, 2024
Description of a novel splice site variant in UBA1 gene causing VEXAS syndromeDaniela Ospina Cardona, Ignasi Rodriguez-Pinto, Sonia Iosim, et al.
The Journal of Molecular Diagnostics : JMD|April 10, 2022
Unraveling Structural Rearrangements of the CFH Gene Cluster in Atypical Hemolytic Uremic Syndrome Patients Using Molecular Combing and Long-Fragment Targeted SequencingNikolai Tschernoster, Florian Erger, Patrick R Walsh, et al.
Kidney International|November 6, 2019
Patients with primary hyperoxaluria type 2 have significant morbidity and require careful follow-upSander F Garrelfs, Gill Rumsby, Hessel Peters-Sengers, et al.
Frontiers in Neuroscience|November 16, 2020
Human iPSC-Derived Neuronal Cells From <i>CTBP1</i>-Mutated Patients Reveal Altered Expression of Neurodevelopmental Gene NetworksS Vijayalingam, Uthayashanker R Ezekiel, Fenglian Xu, et al.
Pageof 72

Showing results (621-630 of 718) with videos related to

Sort By:
Pageof 72
JAMA Dermatology|June 12, 2024
Skin Manifestations of VEXAS Syndrome and Associated GenotypesIsabella J Tan, Marcela A Ferrada, Serene Ahmad, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 16, 2015
Rapid Response to Cyclosporin A and Favorable Renal Outcome in Nongenetic Versus Genetic Steroid-Resistant Nephrotic SyndromeAnja K Büscher, Bodo B Beck, Anette Melk, et al.
Plos One|November 16, 2018
Long-term effects of smallpox vaccination on expression of the HIV-1 co-receptor CCR5 in womenK B Beck, B L Hønge, J S Olesen, et al.
Kidney International Reports|May 20, 2021
Expanding the Spectrum of FAT1 Nephropathies by Novel Mutations That Affect Hippo SignalingFrancesca Fabretti, Nikolai Tschernoster, Florian Erger, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 21, 2025
Clinical Manifestations of VEXAS Syndrome Across a Broad Spectrum of UBA1 Mutation BurdenMeghan Anderson, Defne Ercelen, Ashley Richardson, et al.
Journal of Clinical Medicine|February 27, 2026
PAXIS: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2 Study (Part 1) Followed by an Open-Label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients with VEXAS SyndromeDavid B Beck, Maël Heiblig, Sinisa Savic, et al.
Rheumatology (Oxford, England)|March 29, 2024
Description of a novel splice site variant in UBA1 gene causing VEXAS syndromeDaniela Ospina Cardona, Ignasi Rodriguez-Pinto, Sonia Iosim, et al.
The Journal of Molecular Diagnostics : JMD|April 10, 2022
Unraveling Structural Rearrangements of the CFH Gene Cluster in Atypical Hemolytic Uremic Syndrome Patients Using Molecular Combing and Long-Fragment Targeted SequencingNikolai Tschernoster, Florian Erger, Patrick R Walsh, et al.
Kidney International|November 6, 2019
Patients with primary hyperoxaluria type 2 have significant morbidity and require careful follow-upSander F Garrelfs, Gill Rumsby, Hessel Peters-Sengers, et al.
Frontiers in Neuroscience|November 16, 2020
Human iPSC-Derived Neuronal Cells From <i>CTBP1</i>-Mutated Patients Reveal Altered Expression of Neurodevelopmental Gene NetworksS Vijayalingam, Uthayashanker R Ezekiel, Fenglian Xu, et al.
Pageof 72